Literature DB >> 2462590

An H-2Ld hybrid molecule with a Qa-2 alpha-3 domain and phosphatidyl-inositol anchor is not recognized by H-2Ld-specific cytotoxic T lymphocytes.

D W Mann1, I Stroynowski, L Hood, J Forman.   

Abstract

Ld/Q7d, a hybrid molecule consisting of alpha-1 and alpha-2 domains from H-2Ld and alpha-3 and carboxy-end components from Q7d, was expressed on the surface of CRL-3A rat liver cells. This molecule retained serologic H-2Ld epitopes. The Ag is attached to the cell membrane through a phosphatidyl-inositol linkage, characteristic of Qa-2 molecules. Both bulk cultured and cloned H-2Ld alloreactive CTL as well as H-2Ld restricted vesicular stomatitis virus-specific CTL lyse CRL-3A cells which express H-2Ld but show little or no lytic activity on cells which express the Ld/Q7d hybrid. These cells also fail to act as cold target competitors for alloreactive anti-H-2Ld CTL. However, cells expressing Ld/Q7d are not resistant to CTL mediated lysis because they can be killed in the presence of lectin. These data indicate that recognition of polymorphic class I CTL epitopes in the alpha-1 and alpha-2 domains are influenced by the structure of the carboxy-end of the molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Increased mobility of major histocompatibility complex I-peptide complexes decreases the sensitivity of antigen recognition.

Authors:  Jean-Manuel Segura; Philippe Guillaume; Silke Mark; Danijel Dojcinovic; Alexandre Johannsen; Giovanna Bosshard; Georgi Angelov; Daniel F Legler; Horst Vogel; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2008-06-25       Impact factor: 5.157

2.  The association of H-2Ld with human beta-2 microglobulin induces localized conformational changes in the alpha-1 and -2 superdomain.

Authors:  M C Nieto; E S Song; D McKinney; M McMillan; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.